Liver injury correlates with biomarkers of autoimmunity and disease activity and represents an organ system involvement in patients with systemic lupus erythematosus. [electronic resource]
- Clinical immunology (Orlando, Fla.) Oct 2015
- 319-27 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural
1521-7035
10.1016/j.clim.2015.07.001 doi
Acetylcysteine--therapeutic use Adult Alanine Transaminase--blood Antibodies, Antinuclear--immunology Aspartate Aminotransferases--blood Azathioprine--therapeutic use Biomarkers Cohort Studies Complement System Proteins--immunology Cyclosporine--therapeutic use Diabetes Mellitus--epidemiology Female Free Radical Scavengers--therapeutic use Humans Immunosuppressive Agents--therapeutic use Liver Diseases--drug therapy Longitudinal Studies Lupus Erythematosus, Systemic--drug therapy Male Middle Aged Mycophenolic Acid--analogs & derivatives Prednisone--therapeutic use Prevalence Retrospective Studies Severity of Illness Index Sex Distribution Sirolimus--therapeutic use